Abstract: The invention features a method of delivering DNA to a spermatogonium by infusing DNA in situ into a testicle of a non-human animal and administering a condition or substance to the testicle to increase uptake of DNA by the spermatogonium

Abstract: The invention features a method of delivering DNA to a spermatogonium by infusing DNA in situ into a testicle of a non-human animal and administering a condition or substance to the testicle to increase uptake of DNA by the spermatogonium.

Abstract: A transgenic large mammal is produced by a method including the steps of obtaining one or more early embryos, selectively preparing an embryo having at least three cells, and preferably at a stage in development corresponding in time to the onset of transcription of the embryo's paternal genome, and introducing isolated nucleic acid molecules into a blastomere of the selected embryo. The introduction of isolated nucleic acid molecules into such embryos results in the generation of transgenic large mammals at a significantly increased frequency as compared to introducing isolated nucleic acid molecules into zygotes or into the blastomeres of embryos at the one or two cell stage of development.

Abstract: The invention features an isolated avian gonadal cell, e.g.

Abstract: A DNA comprising at least one inactivated hormone responsive element and a nucleic acid sequence encoding a membrane-associated protein is described. Therapeutic compositions and cells including the DNA are also described. Other aspects of the invention include methods of treating subjects having cystic fibrosis which include administering an effective amount of the DNA to subjects having cystic fibrosis such that functional cystic fibrosis transmembrane conductance regulator is produced by the subject at a level which is not detrimental to the subject. The present invention also pertains to a method of introducing the DNA into a cell such that the membrane-associated protein is produced at a level which is not detrimental to the cell and cells produced by this method.

Abstract: An apparatus for dividing embryos that are maintained in a flushing or saline solution is provided for removable insertion within a test tube-like container having an open container end and a sealed rounded end. The apparatus assembles within or without the container and includes a generally cylindrical partition cup having a rounded end that conforms to the rounded sealed end of the container and an elongated cylindrical central barrel having an elongated chamber, the central barrel having a portion thereof which is placed contiguous to the partition cup. The apparatus also includes an elongated, generally cylindrical embryo guide funnel having a funnel-shaped end further defined by an elongated member. The elongated member further defines a tubular passageway that allows the embryo to pass therethrough for division or bisection by a cutting edge attached to the partition cup and positioned adjacent the passageway.